...
首页> 外文期刊>Genetic Engineering & Biotechnology News: The Information Source of the Biotechnology Industry >A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk ProductGE Healthcare describes how to improve virus load capacity and purity
【24h】

A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk ProductGE Healthcare describes how to improve virus load capacity and purity

机译:从细胞培养到纯化的散装制作医疗保健的可扩展性腺病毒生产过程描述了如何提高病毒负载能力和纯度

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Adenovirus (AdV) vectors are commonly used in cancer gene therapy trials, evaluated in gene therapy, and used in vaccines for various diseases. In this study, we have combined technical evaluation of process steps and process economy calculations, from AdV production in cell culture to purified bulk product in up to 10 L scale18 Human AdV5, expressing the green fluorescent protein (GFP), was used for process development. The cells were lysed using Tween 20 as an alternative to Triton X-100 that is now on the authorization list (Annex XIV) of Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH).
机译:腺病毒(ADV)载体通常用于癌症基因治疗试验,在基因治疗中评估,并用于各种疾病的疫苗。 在这项研究中,我们已经组合了工艺步骤和过程经济计算的技术评估,从细胞培养中的普遍纯化散装产物在高达10L SPACE18人ADV5中,表达绿色荧光蛋白(GFP),用于工艺发育 。 使用Tween 20裂解细胞作为Triton X-100的替代品,该X-100现在正在登记,评估,授权和化学品限制的授权清单(附件XIV)(Accke)。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号